Supporting projects developing innovative technologies for biomedical research, advancing current capabilities for acquiring biomedical knowledge.
Funder: National Institutes of Health
Due Dates: February 5, 2027 (New) | March 5, 2027 (Renewal/resubmission/revision) | June 5, 2027 (New) | July 5, 2027 (Renewal/resubmission/revision) | October 5, 2027 (New) | November 5, 2027 (Renewal/resubmission/revision) | January 7, 2028 (Closing)
Funding Amounts: No budget cap (actual project needs required), up to 5 years; generally 4 years for non-ESIs
Summary: Supports proof-of-concept-backed biomedical technology development toward working prototypes with broad research utility.
Key Information: All aims must focus on technology development; testing specific biological questions and clinical trials are not allowed.
The National Institute of General Medical Sciences (NIGMS), part of NIH, supports focused research and development of innovative technologies that could enable acquisition of biomedical knowledge. This R01 program targets technologies already supported by preliminary data and proof of concept, but facing significant technical hurdles before a working prototype can be developed and validated. Supported tools may include instruments, devices, algorithms, software, chemical reagents and processes, and engineered biological molecules or systems.
Projects should address a broad biomedical research need within the NIGMS mission and significantly advance the state of the art. Validation must use well-characterized test systems rather than investigate untested biological questions. The intended outcome is a functioning, adequately characterized prototype ready for its first application to biomedical research questions.